279 related articles for article (PubMed ID: 9256908)
1. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?
Spencer JM; Tannenbaum A; Sloan L; Amonette RA
Dermatol Surg; 1997 Aug; 23(8):625-30; discussion 630-1. PubMed ID: 9256908
[TBL] [Abstract][Full Text] [Related]
2. Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication?
Nouri K; Spencer JM; Taylor JR; Hayag M; DeVoursney J; Shah N
Dermatol Surg; 1999 Mar; 25(3):183-7; discussion 187-8. PubMed ID: 10193964
[TBL] [Abstract][Full Text] [Related]
3. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.
Rowe DE; Carroll RJ; Day CL
J Dermatol Surg Oncol; 1989 Apr; 15(4):424-31. PubMed ID: 2925988
[TBL] [Abstract][Full Text] [Related]
4. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
5. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
Palmer VM; Wilson PR
Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
[TBL] [Abstract][Full Text] [Related]
6. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
7. Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage.
Wagner RF; Cottel WI
J Am Acad Dermatol; 1987 Dec; 17(6):1047-9. PubMed ID: 3429717
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
Spencer JM
Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
[TBL] [Abstract][Full Text] [Related]
9. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
10. Curettage-electrodesiccation treatment of basal cell carcinomas.
Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
[TBL] [Abstract][Full Text] [Related]
11. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
13. Mohs' micrographic surgery for basal cell carcinoma.
Lawrence CM
Clin Exp Dermatol; 1999 Mar; 24(2):130-3. PubMed ID: 10233670
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
15. Histological and immunohistochemical evaluation of basal cell carcinoma following curettage and electrodessication.
Filho LL; de Oliveira de Avelar Alchorne A; Pereira GC; Lopes LR; de Carvalho TC
Int J Dermatol; 2008 Jun; 47(6):610-4. PubMed ID: 18477158
[TBL] [Abstract][Full Text] [Related]
16. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
[TBL] [Abstract][Full Text] [Related]
17. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread.
Ratner D; Thomas CO; Johnson TM; Sondak VK; Hamilton TA; Nelson BR; Swanson NA; Garcia C; Clark RE; Grande DJ
J Am Acad Dermatol; 1997 Oct; 37(4):600-13. PubMed ID: 9344201
[TBL] [Abstract][Full Text] [Related]
18. Current modalities and new advances in the treatment of basal cell carcinoma.
Ceilley RI; Del Rosso JQ
Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
[TBL] [Abstract][Full Text] [Related]
19. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation.
de Graaf YG; Basdew VR; van Zwan-Kralt N; Willemze R; Bavinck JN
Br J Dermatol; 2006 Mar; 154(3):493-7. PubMed ID: 16445781
[TBL] [Abstract][Full Text] [Related]
20. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
